TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
CBZ

CBIZ Inc

Industrials · Specialty Business Services · listed since 1995

54.60$ +0.0% vs. previous close Closing price · As of: Sep 17, 2026
🔔 Watch stock
Add to watchlist

Assessment

Our Rating

A journalistic assessment by our editorial team at the time of the deep dive — it rates the company, not the entry point. Not investment advice and not a solicitation to buy or sell.

Open questions

The business works in principle, but one material question is open. As long as it stays open, our findings do not carry a quality verdict.

Why this colour

The business itself holds up: recurring services for the middle market, no client concentration, $1,894.2 million of equity and all covenants met as of March 31, 2026 — there is no substance finding in the sense of a going concern warning, negative equity or interest coverage below 1. What is open is the decisive operating question: whether the two billion dollar acquisition pays off has not been proven. Organic growth is only about 1.7 percent, earnings per share sit below the 2023 level, $107.2 million of interest stands against $115.4 million of annual profit, 61.7 percent of the balance sheet is goodwill and intangibles, and the latest record quarter draws a quarter of its profit from a one-time credit. This is the textbook case for yellow: not a sick business, but an unproven transformation. The valuation at roughly 0.8 times revenue is not the reason for this colour — price does not determine this rating. The decision is yours.

What the thesis turns on

Assessment: Opportunities & Risks

CBIZ nearly doubled in size overnight — paid for with roughly two billion dollars of purchase price, $1.55 billion of debt and 12.6 million additional shares. Revenue reached $2,758.0 million in 2025, yet diluted earnings per share of $1.83 still sit below the $2.39 of 2023. Organic growth runs at about 1.7 percent, interest of $107.2 million nearly matches the full-year profit of $115.4 million, and 6.2 million shares will be delivered monthly through the end of 2027. The record quarter ended March 31, 2026 contains a $58.0 million one-time gain from the purchase price settlement while operating income slipped. The bet is legible and dated: if the acquired clients stay and the interest bill falls, the new size will reach the shareholder. Not investment advice.

Business model & market position

Bookkeeping, tax returns, payroll and insurance brokerage for small and mid-sized U.S. companies are recurring, largely non-cyclical services, and no single client carries the result. After the Marcum acquisition closed on November 1, 2024, CBIZ generated revenue of $2,758.0 million in 2025 with more than 9,500 team members, up from $1,104.9 million in 2021.

Quality of growth

The growth was bought: of the $944.5 million revenue increase in 2025, the annual report attributes $914.2 million to acquisitions net of divestitures — leaving roughly 1.7 percent organic. Benefits and Insurance Services, the practice group no acquisition supported, grew 2.1 percent to $409.6 million in 2025.

Earnings per share & dilution

Diluted earnings per share of $1.83 in 2025 sit below the $2.39 of 2023, even though revenue rose 73 percent over the same period. The diluted share count climbed from 50.6 million to 63.2 million. Of 13.6 million shares of stock consideration, 6.2 million are still outstanding and will be delivered in 21 monthly installments from April 1, 2026 — about 11.6 percent of the 53,648,732 shares outstanding as of April 27, 2026.

Leverage & interest burden

Interest expense rose to $107.2 million in 2025 (2024: $34.4 million), close to the entire net income of $115.4 million; average debt stood at $1,517.9 million at 6.56 percent. As of March 31, 2026, $1,551.5 million was outstanding against $28.7 million of cash. The credit agreement requires a total net leverage ratio stepping down from 5.00 to 3.75 and a minimum interest coverage ratio of 3.00; the report states all covenants were met at the reporting date.

Balance sheet quality

As of March 31, 2026, equity of $1,894.2 million sits in a balance sheet of $4,630.0 million, roughly 41 percent. However, $2,856.2 million of that is goodwill and intangibles (61.7 percent of total assets), and goodwill alone exceeds equity at $2,000.3 million. Note 13 of the quarterly report explicitly names failure to achieve the anticipated benefits of the transaction, and further declines in market capitalization, as possible triggers for an impairment charge.

Valuation & market picture

A market capitalization of roughly $2.29 billion (53,648,732 shares at $42.60, as of July 26, 2026) equals about 0.8 times annual revenue and about 1.2 times book value — cheap at first glance. Adding net debt puts enterprise value at roughly $3.8 billion, or 1.4 times revenue. Measured against 2025 earnings per share, the price-to-earnings ratio is about 23. Our data set holds only three analyst estimates.

Worth Noting

CBIZ landed on the research list through our in-house stock scanner "Turnaround Candidates": rank 17 of 62 U.S. hits, turnaround check 7 of 8, as of July 25, 2026. These lists are recalculated every day — rank and score are a dated snapshot. The two mandatory pillars are a gap of at least 50 percent to the all-time high and an Altman Z-score of at least 1.1 with positive equity. Pillar 2 is comfortably met: the Altman Z-score stands at 6.01 (data as of July 26, 2026). Membership hangs on Pillar 1 — the gap to the all-time high is 64.78 percent against a 50 percent threshold; from a price of roughly $60.50 (all-time high about $121, price $42.60 on July 26, 2026) the stock leaves the list without anything changing in the business.

The fiscal year matches the calendar year. The most recent periodic report is the quarterly report 10-Q as of March 31, 2026 (filed April 30, 2026); after that, and up to the data cut-off of July 26, 2026, only a current report 8-K of May 15, 2026 on annual meeting results (Item 5.07), insider filings (Form 4) and beneficial ownership filings were submitted. The report for the quarter ended June 30, 2026 was not yet available. The amendment 10-K/A of March 2, 2026 covers only the re-filing of officer certifications and contains no restatement.

Price and valuation figures are dated anchors, not buy arguments: a share price of $42.60 and a market capitalization of roughly $2.29 billion as of July 26, 2026, calculated on the 53,648,732 shares from the cover page of the quarterly report (April 27, 2026). All balance sheet and earnings figures carry the as-of date of their respective report.

As of July 26, 2026 no takeover, merger or take-private process is under way. The term "the Transaction", used throughout the filings, refers to the acquisition of the Marcum business already completed on November 1, 2024, not to a pending process; accordingly there is no Form S-4, no SC 13E3, no Form 25 and no Form 15.

Possible confusion: CBIZ, Inc. (CBZ) is not the same as CBIZ CPAs, P.C. — the latter is the legally separate CPA firm linked to CBIZ through an administrative service agreement. Marcum LLP also continues to exist as a legal entity; what was acquired was the non-attest business. The former name Century Business Services appears in documents up to 2006.

Stock Watch

This analysis is as of August 26, 2026. Stock Watch will tell you what's changed at CBZ since then.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Price history

Chart

Interactive price chart (TradingView).

52-week range: 25.10 $ to 56.80 $ · Last price: 54.60 $ (As of: September 17, 2026)

Key figures

Key figures at a glance

Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.

Basics

Market Cap ?The value of the entire company on the market: share price times total shares outstanding. 2.9$B
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 54m
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 89.3%
Beta ?Volatility versus the overall market: 1 = moves like the market, 2 = twice as much, under 1 = calmer than the market. 0.9

Performance

Perf. 1M ?Price performance over the last month. 0.00%
Perf. 3M ?Price performance over the last 3 months. 23.70%
Perf. 6M ?Price performance over the last 6 months. -38.40%
YTD Performance (%) ?Price performance since the start of the year (Year to Date). -39.70%
52-Week-High Distance ?How far the price sits below its highest point over the last 52 weeks. 0% means the stock is at its year high. -61.0%
Perf. 1Y ?Price performance over the last 12 months. -3.87%
Perf. 3Y ?Price performance over the last 3 years. 1.60%
Perf. 5Y ?Price performance over the last 5 years. 66.77%
Perf. 10Y ?Price performance over the last 10 years. 395.91%
Perf. Since Inception ?Price performance since the first available trading day (04/27/1995) — with a complete history, that is since the IPO. 3,540.00%

Technical Indicators

MA 38 Days ?Moving average of the last 38 trading days: the smoothed price path. A price above it signals short-term strength. 54.20$
MA 50 Days ?Moving average of the last 50 trading days — the most widely watched medium-term trend line. 51.00$
MA 200 Days ?Moving average of the last 200 trading days — the dividing line between a long-term uptrend and downtrend. 39.80$
RSI (14) ?Relative Strength Index over 14 days, scale 0 to 100: above 70 counts as overbought, below 30 as oversold. A hint on timing, not a verdict on the company. 68.7
Volatility 30 Days ?Price swings over the last 30 trading days, annualized. The higher the value, the more the price fluctuates. 4.5%
Volatility 250 Days ?Price swings over the last 250 trading days (roughly one market year), annualized. 53.4%

Calculated from the price history · as of 09/18/2026

Valuation

P/E ?Price-to-earnings ratio: how many years of profit does the stock cost? The lower, the cheaper the valuation. No earnings means no P/E.
Forward P/E ?P/E based on expected earnings for the next 12 months instead of past earnings — analysts' bet on the future. 12.2
PEG ?P/E divided by expected earnings growth: puts valuation in relation to growth. Around 1 is considered fair, well above that is pricey. 1.2
P/B ?Price-to-book ratio: market value relative to book equity.
P/S ?Price-to-sales ratio: market value divided by annual sales. Important for companies that aren't (yet) profitable. 1.1
EV/EBITDA ?Enterprise value including debt (EV) relative to operating profit before depreciation and amortization (EBITDA) — more comparable than P/E because debt counts too. Extreme values arise when EBITDA is near zero. 13.2
Price/FCF ?Market value divided by free cash flow: how many years of freely available cash does the stock cost? More honest than P/E because cash flow is harder to dress up. 10.4

Profitability

Gross Margin ?Gross margin: what's left of sales after only direct production costs are deducted — the product's pricing power. 15.2%
EBIT Margin ?EBIT margin: operating profit as a percentage of sales — the earning power of the core business before interest and taxes. 25.6%
Net Margin ?Net margin: what's left of sales as profit after ALL costs, interest, and taxes. 4.4%
Return on Equity ?Return on equity: how much profit does the company generate per year on shareholders' equity? 8.1%
Return on Assets ?Return on assets: how much profit the company generates from its total assets (equity and debt combined). 3.9%

Balance Sheet & Safety

Equity Ratio ?Equity ratio: equity as a share of total assets. The higher, the more resilient the balance sheet. 40.9%
Debt/Equity ?Leverage ratio: financial debt divided by equity. Under 1 is generally seen as solid; negative values mean negative equity.
Altman Z″ ?Edward Altman's bankruptcy early-warning score. We use the Z″ variant, built from four balance-sheet ratios — it is designed for service companies and non-manufacturers and uses book value instead of market value. On that scale: below 1.1 = danger zone, 2.6 and up = safe zone, in between a grey area. Because the classic Altman Z is calculated differently, the two numbers are not directly comparable. The formula does not fit banks, insurers, or real-estate stocks. fortress balance sheet 6.01
Piotroski ?Balance-sheet health check by Joseph Piotroski: 9 yes/no criteria on profit, cash flow, leverage, and efficiency. 7+ is very solid, under 3 is a red flag. 5 out of 9

Growth

Sales Growth Last Quarter ?Sales growth in the most recently reported quarter versus the same quarter a year ago (YoY). 1.30%
EPS Growth Last Quarter ?Growth in earnings per share in the most recently reported quarter versus the same quarter a year ago (YoY). 37.70%
Sales Growth (Year) ?Sales growth in the last fiscal year versus the year before. 52.08%
Forward Sales Growth ?Sales growth analysts expect over the next 12 months — an estimate, not a guarantee. 4.27%
Forward EPS Growth ?Earnings-per-share growth analysts expect over the next 12 months — an estimate, not a guarantee. 10.50%

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage ?Weinstein phases 1 through 4: 1 = basing, 2 = uptrend (the only buy phase), 3 = topping, 4 = downtrend. Measured against the 30-week line. 4
RS Rating ?Relative strength from 1 to 99: an RS of 95 means the stock has outperformed 95% of all stocks. 13
EPS Rating ?Earnings growth rating from 1 to 99 versus all stocks — high values mean above-average earnings growth. 74
Fundamental Rating ?Our own Fundamental Rating: 0 to 100 points with an A+ to F grade. 50 points is the average across the universe, 100 the best possible score. It scores growth, earnings surprises, analyst estimates, margins, cash flow, and balance-sheet safety — every stock percentile-ranked against all others. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below. C (49 out of 100)

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Comparison

Industry comparison

The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.

Industry: Specialty Business Services

Industry comparison
Company Market cap ($B) P/E EV/EBITDA Gross Margin % EBIT Margin % Sales Growth (Year) % Perf. 1Y %
CBIZ Inc CBZ 2.9 13.2 15.2 25.6 52.1 -3.9
Cintas Corporation CTAS 79.2 42.9 26.6 50.7 23.2 7.8 0.0
Copart Inc CPRT 27.4 18.7 13.2 49.0 37.5 9.7 -36.4
Global Payments Inc GPN 23.4 31.5 10.9 64.0 12.5 -23.8 1.4
RB Global Inc. RBA 15.7 39.2 13.7 45.8 18.0 9.0 -27.9
Aramark Holdings ARMK 14.9 43.9 15.4 15.3 4.6 6.4 53.5
UL Solutions Inc. ULS 13.0 26.3 15.9 50.4 18.4 6.4 -3.1
Dolby Laboratories DLB 5.4 24.2 13.8 87.6 29.1 5.9 -17.7
Amentum Holdings Inc. AMTM 5.0 34.0 8.2 10.5 4.1 71.6 -9.2
Median of companies shown 14.9 32.7 13.7 49.0 18.4 7.8 -3.9

Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →

Fiscal years

Annual Figures

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

Revenue, operating income and net income per fiscal year $M

Revenue Operating income Net income

2016 · Revenue: 800 $M 2016 · Operating income: 66 $M 2016 · Net income: 40 $M 2017 · Revenue: 855 $M 2017 · Operating income: 66 $M 2017 · Net income: 50 $M 2018 · Revenue: 922 $M 2018 · Operating income: 93 $M 2018 · Net income: 62 $M 2019 · Revenue: 948 $M 2019 · Operating income: 81 $M 2019 · Net income: 71 $M 2020 · Revenue: 964 $M 2020 · Operating income: 92 $M 2020 · Net income: 78 $M 2021 · Revenue: 1,105 $M 2021 · Operating income: 73 $M 2021 · Net income: 71 $M 2022 · Revenue: 1,412 $M 2022 · Operating income: 168 $M 2022 · Net income: 105 $M 2023 · Revenue: 1,591 $M 2023 · Operating income: 165 $M 2023 · Net income: 121 $M 2024 · Revenue: 1,813 $M 2024 · Operating income: 74 $M 2024 · Net income: 41 $M 2025 · Revenue: 2,758 $M 2025 · Operating income: 234 $M 2025 · Net income: 115 $M
2016201720182019202020212022202320242025
Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2016 800 66 40 0.75 71 471 1,119
2017 855 66 50 0.90 72 491 1,176
2018 922 93 62 1.09 105 509 1,098
2019 948 81 71 1.27 98 659 1,435
2020 964 92 78 1.41 147 703 1,558
2021 1,105 73 71 1.32 131 705 1,673
2022 1,412 168 105 2.01 126 713 1,927
2023 1,591 165 121 2.39 154 792 2,044
2024 1,813 74 41 0.78 124 1,780 4,471
2025 2,758 234 115 1.83 192 1,762 4,410

Quarters

Quarterly Figures

Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 460.3 $M Q4 2025: Q1 · 838.0 $M Q1 2025: Q2 · 683.5 $M Q2 2025: Q3 · 693.8 $M Q3 2025: Q4 · 542.7 $M Q4 2026: Q1 · 848.6 $M Q1 2026: Q2 · 682.2 $M Q2

Source: fundamental data

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 -1.53 460 40.50 -19.70 56 52
2025: Q1 1.91 25.00 838 69.50 14.70 -88 -93
2025: Q2 0.66 67.00 684 62.70 6.10 113 105
2025: Q3 0.47 -31.90 694 58.10 4.30 24 22
2025: Q4 -1.26 543 17.90 -14.60 144 142
2026: Q1 2.49 30.40 849 1.30 19.00 -26 -29
2026: Q2 0.31 -53.00 682 -0.20 2.70 148 148

What Do These Terms Mean?

EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Compare with other stocks →

Screening

Appears in These Scanners

This stock currently matches 7 of our scanner strategies — each hit links to the scanner.

Quality & Balance Sheet

Breakout & Setup

Momentum & Trend

Research

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners

Outlook

Analysts & Price Target

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Consensus Strong Sell 1 = Strong buy … 5 = Strong sell
Analyst Ratings 3
Price Target (average) 55.00$
Distance to price 0.7% The price target sits 0.7% above the current price.

Distribution of Recommendations

Strong Buy 2
Buy 1
Hold 0
Sell 0
Strong Sell 0

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
12/31/2026 4.03 3.60 – 4.29 2,823 11.5% 4
12/31/2027 4.25 3.55 – 4.60 2,951 5.5% 4

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Valuation

What is priced in?

Instead of guessing what the stock is worth, we turn the question around: what free cash flow growth has to happen for today’s market value to add up? The assumptions behind it can be moved.

Today’s market value implies roughly -1.5% growth in free cash flow per year over ten years (assumptions: discount rate 10.0%, terminal growth 2.5%).

What is priced in?
Free cash flow (last twelve months) $286.0M
Market cap $2.93B
Free cash flow in year ten $245.5M
Terminal value as a share of market value 44.1%

For comparison: over the past five years free cash flow grew by 5.3% per year.

It shows which assumption is built into today’s price, not whether that assumption will hold. Every assumption can be changed with the sliders; the figures move with them.

A simplified model calculation — not a forecast and not a recommendation.

AI classification

AI Rating

Threatened

CBIZ weist in beiden 10-K und im 10-Q zum 1. Quartal 2025 künstliche Intelligenz und Automatisierung ausdrücklich als Wettbewerbsgefahr für das eigene Dienstleistungsgeschäft aus — Kunden könnten die eigenen Leistungen dadurch reduzieren oder umgehen —, während die Filings keine KI-Produkte oder KI-Dienste als Umsatzquelle benennen.

View the full file — quotes, sources, reviewed filings
„Those technological changes may (i) reduce demand for our services, (ii) enable the development of competitive products or services, or (iii) enable our current customers to reduce or bypass the use of our services. Additionally, rapid changes in artificial intelligence, block chain-based technology, automation and related innovations are increasing the competitiveness landscape."

Diese technologischen Veränderungen können (i) die Nachfrage nach unseren Leistungen verringern, (ii) die Entwicklung konkurrierender Produkte oder Dienstleistungen ermöglichen oder (iii) es unseren derzeitigen Kunden ermöglichen, die Inanspruchnahme unserer Leistungen zu verringern oder zu umgehen. Darüber hinaus verschärfen rasche Veränderungen bei künstlicher Intelligenz, Blockchain-basierter Technologie, Automatisierung und verwandten Innovationen das Wettbewerbsumfeld.

10-K · 2026-02-26 · View SEC filing

„If we are not successful in anticipating or responding to technological changes, we may not generate a return on these investments and demand for our services could be further reduced by advanced technologies being deployed by our competitors."

Wenn es uns nicht gelingt, technologische Veränderungen vorherzusehen oder auf sie zu reagieren, erzielen wir möglicherweise keine Rendite auf diese Investitionen, und die Nachfrage nach unseren Leistungen könnte durch fortschrittliche Technologien, die unsere Wettbewerber einsetzen, weiter sinken.

10-K · 2025-02-28 · View SEC filing

„The professional business services industry has been and continues to be impacted by significant technological changes and innovation, enabling companies to offer services competitive with ours."

Die Branche der professionellen Unternehmensdienstleistungen war und ist weiterhin von erheblichen technologischen Veränderungen und Innovationen betroffen, die es Unternehmen ermöglichen, Leistungen im Wettbewerb zu unseren anzubieten.

10-Q · 2025-04-25 · View SEC filing

„Mr. Scavuzzo’s responsibilities apply to projects related to transformation, innovation, artificial intelligence, business intelligence and data analytics as well as overseeing the organization’s Technology business division."

Die Zuständigkeiten von Herrn Scavuzzo betreffen Projekte in den Bereichen Transformation, Innovation, künstliche Intelligenz, Business Intelligence und Datenanalyse sowie die Leitung des Technologie-Geschäftsbereichs des Unternehmens.

10-K · 2026-02-26 · View SEC filing

Filings Reviewed: 10-Q 2026-04-30 · 10-K 2026-02-26 · 10-Q 2025-10-30 · 10-Q 2025-07-31 · 10-Q 2025-04-25 · 10-K 2025-02-28

Rated on July 26, 2026 · How the Rating Is Built

Growth

Growth Score

Ten checks against the annual reports — each one passed counts a point.

3 of 10 Weak growth
  • Revenue grows by more than 15% a year over three years 25.0%
  • More than 10% revenue growth is expected for the coming year 4.3%
  • Share count grows by less than 3% a year 6.5%
  • Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 58.5%
  • Gross margin at 40% or higher and without meaningful erosion 12.9%
  • Goodwill from acquisitions does not grow faster than revenue 52.8%
  • Net debt below twice EBITDA 4.9 x EBITDA
  • Operating cash flow covers the profits of the last three years 192 m
  • Return on capital at 15% or higher, or up versus two years ago 6.4%
  • Insiders hold at least 10% or are net buyers 5.0%

A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail

Quality check

AAQS

5/10

The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).

  • Sales growth 10Y > 5% 14.7%
  • Exp. sales growth 3Y > 5% 3.4%
  • EBIT growth 10Y > 5% 15.1%
  • Exp. EBIT growth 3Y > 5% 52.5%
  • Net debt < 4x EBIT 7.7x
  • EBIT positive, 10Y straight 10
  • Max. EBIT decline < 50% 56.2%
  • Return on equity > 15%
  • ROCE > 15% 6.4%
  • Expected return > 10% 61.7%

View stocks with the full AAQS score · Read the methodology at AlleAktien

Source: fundamental data

Insiders

Insider Transactions

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

Insider Transactions
Date Person Role Type Shares Price Value
Aug 4, 2026 Sherman A Haag Director Other 22,354 55.07 1,231,035
Aug 4, 2026 Sherman A Haag Director Other 50,000 24.62 1,231,000

View all insider transactions →

The company

About the Company

CBIZ, Inc. bietet Finanz-, Versicherungs- und Beratungsdienstleistungen in den USA und Kanada an.

Employees
9,500
Headquarters
Independence, OH
Address
5959 Rockside Woods Blvd. North, 44131 Independence, United States
Phone
216 447 9000
Website
cbiz.com
IPO Date
04/27/1995
ISIN
US1248051021
Stock Split
2:1 on 07/01/1996

Management

Management
Name Title Birth Year
Jerome P. Grisko Jr. President, CEO & Director 1962
Brad S. Lakhia Senior VP & CFO 1972
Michael P. Kouzelos CPA President of Benefits & Insurance Services, Inc. 1969
Michael Mangan Chief Accounting Officer 1969
Christopher Sikora Vice President of Investor Relations & Corporate Finance
Peter Scavuzzo Senior VP, Chief Information & Technology Officer and President of CBIZ Technology 1977
Jaileah X. Huddleston Senior VP, Chief Legal Officer & Corporate Secretary 1978
Amy McGahan Director of Corporate & Strategic Communications
Matthew Joseph Morelli Senior Vice President of Corporate Development 1970
Donna M. Mirandola Senior VP & Chief Marketing Officer 1978

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Filings

Company Filings (8-K)

An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).

  • 07/29/2026 CBIZ, Inc. (CBZ): Results of Operations and Financial Condition; Financial Statements and Exhibits SEC ↗
  • 07/29/2026 CBIZ, Inc. (CBZ): Other Events SEC ↗
  • 07/29/2026 CBIZ, Inc. (CBZ): Entry into a Material Definitive Agreement; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits SEC ↗

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?